[1]CurrentPatentAssignee:REVOLMEDICAL;RYVUTHERAPEUTICSSA-WO2021/116451,2021,A1Locationinpatent:Page/Pagecolumn82-83
[2]CurrentPatentAssignee:RYVUTHERAPEUTICSSA;REVOLMEDICAL-WO2021/116446,2021,A1Locationinpatent:Page/Pagecolumn119
173340-25-5
1016167-99-9
1017356-25-0
1174020-26-8
114459-62-0
1147422-00-1
1218790-88-5 | 4-Hydroxymethyl-3-methylphenylboronic acid | AA00167D | MFCD09996880
1219828-33-7 | 1-(Ethanesulfonyl)azetidine-3-carboxylic acid | AA0016EW | MFCD16653315
1221171-70-5 | 2-Chloro-6-(trifluoromethoxy)pyridine | AA0016P9 | MFCD18909427
122306-01-8 | (6-Bromo-pyridin-3-yl)methanol | AA00170J | MFCD04974508
122536-94-1 | (S)-Pyrrolidin-3-ol, HCl | AA0017CX | MFCD00272298
138-59-0 | Shikimic acid | AA0017Q7 | MFCD00066278
1381944-57-5 | 2-(3-Fluorophenyl)-2-methylpropan-1-amine, HCl | AA00183W | MFCD22375032
138372-67-5 | 2,2'-(1,3-Phenylene)bis[5-(4-tert-butylphenyl)-1,3,4-oxadiazole] | AA0018L1 | MFCD03093214
1384972-83-1 | 3-(Bromomethyl)-4-methylpyridine hydrobromide | AA00197R | MFCD26743700
1389264-12-3 | Cis-tert-butyl 3-iodocyclobutylcarbamate | AA0019RW | MFCD22415233